CLINICAL-TRIALS EVALUATING PLATELET-MODIFYING DRUGS IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE AND THROMBOSIS

被引：53

作者：

HARKER, LA

机构：

来源：

CIRCULATION | 1986年 / 73卷 / 02期

关键词：

D O I：

10.1161/01.CIR.73.2.206

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：206 / 223

页数：18

共 99 条

[1] CONTROLLED TRIAL OF DIPYRIDAMOLE IN CEREBRAL VASCULAR DISEASE [J].

ACHESON, J ;

DANTA, G ;

HUTCHINSON, EC .

BMJ-BRITISH MEDICAL JOURNAL, 1969, 1 (5644) :614-+

[2]

ALI M, 1977, J LAB CLIN MED, V89, P868

[3]

ALTMAN R, 1976, J THORAC CARDIOV SUR, V72, P127

[4]

[Anonymous], 1976, J Chronic Dis, V29, P625

[5]

[Anonymous], 1980, CIRCULATION, V62, P449

[6]

[Anonymous], 1975, JAMA, V231, P360

[7]

[Anonymous], 1978, N ENGL J MED, V299, P53

[8]

Anturane Reinfarction Trial Research Group, 1978, N Engl J Med, V298, P289

[9]

BAUR HR, 1982, AM J CARDIOL, V49, P420, DOI 10.1016/0002-9149(82)90519-7

[10] AICLA CONTROLLED TRIAL OF ASPIRIN AND DIPYRIDAMOLE IN THE SECONDARY PREVENTION OF ATHERO-THROMBOTIC CEREBRAL-ISCHEMIA [J].

BOUSSER, MG ;

ESCHWEGE, E ;

HAGUENAU, M ;

LEFAUCCONNIER, JM ;

THIBULT, N ;

TOUBOUL, D ;

TOUBOUL, PJ .

STROKE, 1983, 14 (01) :5-14

← 1 2 3 4 5 6 7 8 9 10 →